Head-to-head · WeighScore
Calibrate Health vs Lttl
The verdict
Calibrate Health takes it — 69.3/100 to 66.1/100.
Calibrate Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Calibrate Health is a year-long metabolic-reset program pairing branded GLP-1 medication (Wegovy, Ozempic, Zepbound, or Foundayo) with 1:1 video coaching and dietitian support — a deeper clinical wrap than…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Calibrate Health | Lttl |
|---|---|---|
| WeighScore | 69.3/100 | 66.1/100 |
| Grade | C | C |
| Scorecard rank | #125 | #204 |
| Semaglutide | Not disclosed | $199/mo (all doses, compounded) |
| Tirzepatide | Not disclosed | $279/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #125 · C
Strengths
- Year-long program with 1:1 video coaching, dietitian support, and behavior-change curriculum — a deeper clinical wrap than transactional telehealth
- $199/month program fee is competitive; medication co-pay can drop to ~$25/month with insurance and a manufacturer savings card
- Branded GLP-1s only (Wegovy, Ozempic, Zepbound, Foundayo) — no compounded products
- Insurance navigation team works to maximize coverage and reportedly accepts most major commercial plans
- Money-back guarantee tied to a 10% weight-loss outcome over the program year
Where it loses points
- Medication cost is on top of the $199/month fee; cash-pay patients face full manufacturer pricing
- Insurance navigation only helps if your plan actually covers branded GLP-1s for weight loss — many don't
- Meaningfully more expensive than compounded telehealth if your insurance denies coverage
- Distinct from 'Oxford's Medical Weight Loss (The Calibrate Clinic)' — don't confuse the two
- Initial 3-month commitment required ($597 total, billed as $199/mo) before it renews month-to-month — more lock-in than month-to-month rivals
Graded #204 · C
Strengths
- Publishes the full price matrix — every medication, form and commitment length — on a public /plans page before checkout
- Flat dose pricing: 'Same price at every dose,' so moving to a higher dose does not raise the monthly bill
- States plainly that its compounded GLP-1s 'are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality'
- Microdose line prices low-dose semaglutide or tirzepatide at $149/mo month-to-month for people sensitive to side effects
- Oral ODT semaglutide offered for members who want to avoid injections
Where it loses points
- Partner pharmacies are never named — the site refers only to 'a partner U.S. pharmacy' (a material disclosure gap for a YMYL purchase)
- The advertised 'Plans start at $129/mo' is the 12-month prepay rate; true month-to-month is $199 semaglutide and $279 tirzepatide
- No public list of states served — eligibility depends on where unnamed 'partner providers are licensed'
- Site banner promises 'Prescribed and shipped within 48 hours' while the shipping policy states 2-5 business days to process plus 3-7 to deliver
- Medications cannot be returned or refunded once they ship from the pharmacy
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.